Clinical Trial Update: Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on vestipitant alone or in combination with paroxetine for tinnitus (with hearing loss) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinnitus

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)
• Vestipitant (vestipitant)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tinnitus | Phase 2 | Status: COMPLETED